BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30356637)

  • 1. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
    Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
    Front Immunol; 2018; 9():2322. PubMed ID: 30356637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
    Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; ; Stratov I; Navis M; Kent SJ
    Immunology; 2013 Feb; 138(2):116-23. PubMed ID: 23173935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
    Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
    EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
    Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
    Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.
    Veillette M; Désormeaux A; Medjahed H; Gharsallah NE; Coutu M; Baalwa J; Guan Y; Lewis G; Ferrari G; Hahn BH; Haynes BF; Robinson JE; Kaufmann DE; Bonsignori M; Sodroski J; Finzi A
    J Virol; 2014 Mar; 88(5):2633-44. PubMed ID: 24352444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.
    Fisher KL; Mabuka JM; Sivro A; Ngcapu S; Passmore JS; Osman F; Ndlovu B; Abdool Karim Q; Abdool Karim SS; Chung AW; Baxter C; Archary D
    Front Immunol; 2020; 11():1274. PubMed ID: 32733445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
    Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
    J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
    Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
    Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure.
    Chung AW; Isitman G; Navis M; Kramski M; Center RJ; Kent SJ; Stratov I
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7505-10. PubMed ID: 21502492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NK cells by ADCC responses during early HIV infection.
    Chung AW; Navis M; Isitman G; Centre R; Finlayson R; Bloch M; Gelgor L; Kelleher A; Kent SJ; Stratov I
    Viral Immunol; 2011 Apr; 24(2):171-5. PubMed ID: 21449728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
    Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
    PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NK cells by ADCC antibodies and HIV disease progression.
    Chung AW; Navis M; Isitman G; Wren L; Silvers J; Amin J; Kent SJ; Stratov I
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):127-31. PubMed ID: 21792067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
    Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
    J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
    Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
    J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.